Journal Club - Elevated serum creatinine levels may up CVD risk in females

Published On 2022-05-11 06:00 GMT   |   Update On 2022-05-11 06:00 GMT

Vascular calcification (VC) is known to be a strong predictor of cardiovascular events and all-cause mortality in CVD. Renal dysfunction is closely associated with VC. Serum creatinine as an important indicator of renal function in chronic kidney disease (CKD), is closely related to increased Vascular calcification. The study was published in the journal BMC Cardiovascular...

Login or Register to read the full article

Vascular calcification (VC) is known to be a strong predictor of cardiovascular events and all-cause mortality in CVD. Renal dysfunction is closely associated with VC. Serum creatinine as an important indicator of renal function in chronic kidney disease (CKD), is closely related to increased Vascular calcification.

The study was published in the journal BMC Cardiovascular Disorders.

Measuring the levels of serum creatinine would be helpful in the early screening of individuals at high risk of developing cardiovascular disease (CVD). Further, the researchers stress that higher attention is to be given to females' serum creatinine levels in daily clinical practice.

The study included a total of 9067 participants aged more than 45 years. All participants underwent postero-anterior chest X-ray examination for aortic arch calcification diagnosis.

Serum creatinine level in the female AAC group was significantly higher than that in the non-AAC group, while there was no significant difference in male serum creatinine between the two groups.

These results imply that the role of serum creatinine levels in AAC and CVD development remains under recognised and undertreated in the general population. Hence, AAC or asymptomatic CVD risk screening should be given for female with increased serum creatinine levels, especially in individuals concomitant with other CVD risk factors.

Dementia we all know is loss of memories, frontotemporal dementia usually experience an early onset, often while still of working age. In addition, the progression of the disease is rapid and the average survival time after diagnosis is usually eight years. There is no cure, or treatment to slow progression. Therefore, any new knowledge of the disease is valuable. 

Tags:    
Advertisement

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News